Public-private partnerships in addressing counterfeit medicines: The development of the Partnership for Safe Medicines and the Partnership for Safe Medicines-India

Author： LaGanga Scott  

Publisher： Palgrave Macmillan Ltd

ISSN： 1478-565X

Source： Journal of Commercial Biotechnology, Vol.17, Iss.3, 2011-08, pp. : 260-265

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biotechnology in India: Public–private partnerships

By Konde Viren  

Journal of Commercial Biotechnology, Vol. 14, Iss. 1, 2008-01 ,pp. : 43-55

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

Enforcement efforts and partnership with industry: A needed strategy addressing counterfeit drugs

By Kubic Thomas T  

Journal of Commercial Biotechnology, Vol. 17, Iss. 3, 2011-08 ,pp. : 254-259

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

Regulatory data protection for medicines

By Wilkinson John  

Journal of Commercial Biotechnology, Vol. 11, Iss. 1, 2004-10 ,pp. : 87-96

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

Public-private partnerships in global health

By Liang Bryan A  

Journal of Commercial Biotechnology, Vol. 17, Iss. 3, 2011-08 ,pp. : 230-232

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

New approaches to global health governance: The evolution to public-private partnerships

By Balcius James   Novotny Thomas E  

Journal of Commercial Biotechnology, Vol. 17, Iss. 3, 2011-08 ,pp. : 233-240

Palgrave Macmillan Ltd

Access to resources Recommend Favorite